Pfizer Inc. (PFE) Stock Soars on ‘Near to End’ COVID-19 Vaccine
The COVID-19 vaccine succeeds in the final stage trials while Pfizer agrees to make a $60 million equity investment in Homology. Shares of Pfizer, Inc. (PFE) soared up to 13% in the premarket following the update on the Phase 3 trials of the COVID-19 vaccine.